InvestorsHub Logo
Post# of 252816
Next 10
Followers 0
Posts 348
Boards Moderated 0
Alias Born 06/10/2009

Re: None

Friday, 02/04/2011 10:49:46 PM

Friday, February 04, 2011 10:49:46 PM

Post# of 252816
EXEL: Is there anything unique to EXEL's tyrosine kinase inhibitor that distinguishes them from other TKI's? There seems to be handfuls of companies studying TKI's with limited success.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.